Evidence map›Paper›PMID 33822083›Full record

ArticleThe Journal of infectious diseases2021

Diminished Circulating Levels of Angiogenic Factors and Rage Ligands in Helminth-Diabetes Comorbidity and Reversal Following Anthelmintic Treatment.

Anuradha Rajamanickam, Saravanan Munisankar, Pradeep A Menon, Thomas B Nutman, Subash Babu

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anuradha RajamanickamInternational Center for Excellence in Research, National Institute of Health, Chennai, India.ORCID 0000-0002-8143-5502
Saravanan MunisankarInternational Center for Excellence in Research, National Institute of Health, Chennai, India.
Pradeep A MenonNational Institute for Research in Tuberculosis, Chennai, India.
Thomas B NutmanLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Subash BabuInternational Center for Excellence in Research, National Institute of Health, Chennai, India.

Funding

Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic InfectionZIAAI000197 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$23.4M
India International Center for Excellence in ResearchZIAAI001065 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$19.0M
6 · The paper itself

Abstract

backgroundVarious epidemiological and experimental studies propose that helminths could play a preventive role against the progression of type 2 diabetes mellitus (T2DM). T2DM induces microvascular and large vessel complications mediated by elevated levels of angiogenic factors and soluble receptor for advanced glycation end product (RAGE) ligands. However, the interactions between helminths and host angiogenic factors and RAGE ligands are unexplored.

methodsTo assess the relationship between a soil-transmitted helminth, Strongyloides stercoralis (Ss), and T2DM, we measured plasma levels of vascular endothelial growth factor (VEGF)-A, -C, and -D; angiopoietins 1 and 2 (Ang-1 and Ang-2); and their receptors VEGF-R1, -R2, and -R3 as well as soluble RAGE (sRAGE) and their ligands advanced glycation end products (AGEs), S100A12, and high mobility group box 1 (HMGB-1) in individuals with T2DM with or those without Ss infection. In Ss-infected individuals, we also measured the levels of aforementioned factors 6 months following anthelmintic therapy.

resultsSs-infected individuals exhibited significantly decreased levels of VEGF-A, VEGF-C, VEGF-D, Ang-1, and Ang-2 and their soluble receptors VEGF-R1, -R2, and -R3, that increased following anthelmintic therapy. Likewise, Ss-infected individuals exhibited significantly decreased levels of AGEs and their ligands sRAGE, S100A12, and HMGB-1, which reversed following anthelmintic therapy.

conclusionsOur data suggest that Ss infection could play a beneficial role by limiting or delaying T2DM-related vascular complications.

Indexed as

Angiogenesis Inducing AgentsAnimalsAnthelminticsAntigens, NeoplasmComorbidityDiabetes Mellitus, Type 2HelminthsHMGB1 ProteinHumansMitogen-Activated Protein KinasesReceptor for Advanced Glycation End ProductsReceptors, ImmunologicS100A12 ProteinS100 ProteinsStrongyloides stercoralisStrongyloidiasisAngiogenesis Inducing AgentsAnthelminticsAntigens, NeoplasmHMGB1 ProteinMitogen-Activated Protein KinasesMOK protein, humanReceptor for Advanced Glycation End ProductsReceptors, ImmunologicS100A12 ProteinS100A12 protein, humanS100 ProteinsVascular Endothelial Growth Factor Aangiogenic factorsHMGB-1RAGE ligandsS100A12Strongyloides stercoralis infectiontype 2 diabetes mellitusVEGFs and receptors

Identifiers

PMID33822083
PMCPMC8599919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.